Effect of platelet-rich plasma injection in the ovaries of patients with unilateral endometriosis on the amount of ovarian reserve after surgery

Investigating the effect of platelet-rich plasma injection in the ovaries of patients with unilateral endometriosis on the amount of ovarian reserve after surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241225064169N2

Enrollment

Registered

2025-02-21

Start date

2025-03-10

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Endometriosis

Interventions

Intervention 1: Intervention group: For the intervention group, platelet-rich plasma (PRP) prepared from the patients own blood will be injected into the ovaries after endometriosis surgery (35 patien

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women with unilateral ovarian endometriosis ?Aged between 18 and 40 years Menstrual cycles AMH levels above 0.5 ng/mL

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Women in established menopause Women with known genetic causes for DOR Women with secondary causes of infertility such as recurrent pelvic infections, previous ovarian surgery, history of chemotherapy, acute or chronic endometriosis, and endometritis

Design outcomes

Primary

Measure	Time frame
Ovarian reserve (AMH). Timepoint: Before surgery and 6 months after surgery. Method of measurement: AMH levels will be measured using a kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Shakeri

Shiraz University of Medical Sciences

mozhgan.shakeri@gmail.com0098712332365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026